BDSX Logo

Biodesix, Inc. (BDSX) 

NASDAQ
Market Cap
$188.38M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
157 of 966
Rank in Industry
9 of 53

Largest Insider Buys in Sector

BDSX Stock Price History Chart

BDSX Stock Performance

About Biodesix, Inc.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions; and GeneStrat NGS (NGS) test, a 72-hour blood-based NGS test. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado.

Insider Activity of Biodesix, Inc.

Over the last 12 months, insiders at Biodesix, Inc. have bought $821,546 and sold $220,281 worth of Biodesix, Inc. stock.

On average, over the past 5 years, insiders at Biodesix, Inc. have bought $28.65M and sold $198,219 worth of stock each year.

Highest buying activity among insiders over the last 12 months: SCHULER JACK W () — $2.96M. Strobeck Matthew (director) — $223,664. PATIENCE JOHN (Chairman) — $207,420.

The last purchase of 100,000 shares for transaction amount of $122,840 was made by SCHULER JACK W () on 2024‑11‑21.

List of Insider Buy and Sell Transactions, Biodesix, Inc.

2024-11-21Purchase
100,000
0.0687%
$1.23$122,840+12.92%
2024-11-21Purchase
35,000
0.0227%
$1.16$40,562+12.92%
2024-11-20Purchase
200,000
0.1375%
$1.17$234,000+13.45%
2024-11-12SalePresident & CEO
1,813
0.0013%
$1.40$2,540-3.57%
2024-11-12SaleCFO, Sec'y & Treasurer
471
0.0003%
$1.40$660-3.57%
2024-11-12SaleChief Development Officer
207
0.0001%
$1.40$290-3.57%
2024-11-12SaleChief Commercial Officer
224
0.0002%
$1.40$314-3.57%
2024-11-12SaleChief Accounting Officer
98
<0.0001%
$1.40$137-3.57%
2024-11-11SalePresident & CEO
1,927
0.0013%
$1.39$2,680-4.26%
2024-11-11SaleCFO, Sec'y & Treasurer
500
0.0003%
$1.39$695-4.26%
2024-11-11SaleChief Development Officer
220
0.0001%
$1.39$306-4.26%
2024-11-11SaleChief Commercial Officer
238
0.0002%
$1.39$331-4.26%
2024-11-11SaleChief Accounting Officer
105
<0.0001%
$1.39$146-4.26%
2024-11-06Purchase
20,000
0.0139%
$1.36$27,180+1.88%
2024-11-05Purchase
100,253
0.0679%
$1.36$136,585-0.91%
2024-11-05Purchase
51,200
0.0348%
$1.36$69,888-1.10%
2024-11-05Purchasedirector
40,000
0.0278%
$1.40$55,916-3.43%
2024-11-05PurchaseChairman
75,000
0.0516%
$1.38$103,710-2.37%
2024-11-05Purchasedirector
22,500
0.0154%
$1.37$30,866-1.59%
2024-08-12SalePresident & CEO
963
0.0007%
$1.57$1,514+4.97%

Insider Historical Profitability

<0.0001%
SCHULER JACK W
31194935
21.4447%
$1.30310<0.0001%
Kennedy Lawrence T. Jr
10411024
7.157%
$1.3050+22.69%
Strobeck Matthewdirector
2606879
1.7921%
$1.3060+0.18%
PATIENCE JOHNChairman
2153298
1.4803%
$1.30100<0.0001%
Hutton ScottPresident & CEO
532979
0.3664%
$1.30220<0.0001%
Cowie Robin HarperCFO, Sec'y & Treasurer
203336
0.1398%
$1.30220<0.0001%
Pestano Gary AnthonyChief Development Officer
127027
0.0873%
$1.30020
O'Kane KieranChief Commercial Officer
97448
0.067%
$1.30020
MASSARANY HANYdirector
53364
0.0367%
$1.3040+21.75%
Vazquez ChrisChief Accounting Officer
11587
0.008%
$1.30011
Kayyem Jon Faizdirector
173913
0.1196%
$1.3020+22.69%
Watts Charles Mdirector
51333
0.0353%
$1.3040+1.45%
Siurek Ryan HChief Accounting Officer
40268
0.0277%
$1.3009
Georgantas Robert William IIIChief Scientific Officer
26114
0.018%
$1.3016+19.87%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Birchview Capital Lp$7.42M4.535.19M0%+$00.41
Aigh Capital Management Llc$4.75M2.93.32M-28.72%-$1.91M2.72
Telemark Asset Management LLC$1.9M1.161.33M+1,644.74%+$1.79M0.21
ESSEX INVESTMENT MANAGEMENT CO LLC$1.32M0.81925,614+1.39%+$18,116.670.27
Wells Fargo$1.28M0.78893,203+1.08%+$13,656.51<0.0001
The Vanguard Group$1.16M0.7807,928-0.47%-$5,466.89<0.0001
Opaleye Management Inc$764,560.000.47534,657+7.68%+$54,564.540.17
BlackRock$576,158.000.35402,908-0.38%-$2,220.79<0.0001
Geode Capital Management$550,853.000.34385,145+7.85%+$40,085.57<0.0001
Legato Capital Management Llc$478,063.000.29334,3100%+$00.06
State Street$393,751.000.24275,3500%+$0<0.0001
Bridgeway Capital Management$328,418.000.2229,663+0.2%+$662.090.01
Spears Abacus Advisors LLC$294,015.000.18205,605New+$294,015.000.01
Susquehanna International Group$272,238.000.17190,376+1,109.58%+$249,731.20<0.0001
Hightower Advisors$188,000.000.12131,4340%+$0<0.0001
Millennium Management LLC$144,080.000.09100,755+10.33%+$13,492.08<0.0001
Allworth Financial Lp$142,044.000.0999,331+77.84%+$62,173.83<0.01
Jane Street Capital$132,825.000.0892,885+112.06%+$70,189.83<0.0001
Blair William Co Il$114,114.000.0779,800-11.14%-$14,300.00<0.0001
Cetera Advisor Networks LLC$111,540.000.0778,0000%+$0<0.01
CETERA INVESTMENT ADVISERS LLC$111,540.000.0778,000New+$111,540.00<0.0001
Citigroup$101,939.000.0671,286+67.23%+$40,982.38<0.0001
Qube Research & Technologies$99,381.000.0669,497+5.93%+$5,559.86<0.0001
Northern Trust$46,911.000.0332,805+5.44%+$2,419.55<0.0001
Oracle Investment Management Inc$43,402.000.0330,351-50.19%-$43,740.910.01
Goldman Sachs$39,379.000.0227,538New+$39,379.00<0.0001
Charles Schwab$29,489.000.0220,6220%+$0<0.0001
Ci Private Wealth Llc$22,161.000.0115,4970%+$0<0.0001
Squarepoint Ops LLC$19,511.000.0113,644New+$19,511.00<0.0001
Renaissance Technologies$19,000.000.0113,200-72.95%-$51,242.42<0.0001
Cibc Private Wealth Group Llc$19,257.000.0113,1000%+$0<0.0001
Jefferies Financial Group$16,302.000.0111,400New+$16,302.00<0.0001
OMERS$16,046.000.0111,221New+$16,046.00<0.0001
NWAM, LLC$15,500.000.0110,000New+$15,500.00<0.01
Brevan Howard Capital Management Lp$15,051.000.0110,525New+$15,051.00<0.01
Barclays$13,000.000.019,2910%+$0<0.0001
Morgan Stanley$13,118.000.019,173-9.49%-$1,375.72<0.0001
Tower Research Capital$11,051.000.017,728-12.52%-$1,581.57<0.0001
Bank of America$6,700.00<0.014,685-56.26%-$8,617.76<0.0001
Simplex Trading Llc$1,000.00<0.011,071New+$1,000.00<0.0001
Macquarie Group$1,000.00<0.01512New+$1,000.00<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.